These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 25438054)
1. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. Ma B; Chen Y; Chen L; Cheng H; Mu C; Li J; Gao R; Zhou C; Cao L; Liu J; Zhu Y; Chen Q; Wu S Nat Cell Biol; 2015 Jan; 17(1):95-103. PubMed ID: 25438054 [TBL] [Abstract][Full Text] [Related]
2. Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways. Ma B; Cheng H; Gao R; Mu C; Chen L; Wu S; Chen Q; Zhu Y Nat Commun; 2016 Mar; 7():11123. PubMed ID: 27030211 [TBL] [Abstract][Full Text] [Related]
3. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway. Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995 [TBL] [Abstract][Full Text] [Related]
4. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling. Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830 [TBL] [Abstract][Full Text] [Related]
5. Mutual regulation between Polo-like kinase 3 and SIAH2 E3 ubiquitin ligase defines a regulatory network that fine-tunes the cellular response to hypoxia and nickel. Li C; Park S; Zhang X; Dai W; Xu D J Biol Chem; 2017 Jul; 292(27):11431-11444. PubMed ID: 28515325 [TBL] [Abstract][Full Text] [Related]
6. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. Rashidian J; Le Scolan E; Ji X; Zhu Q; Mulvihill MM; Nomura D; Luo K Sci Signal; 2015 Feb; 8(363):ra14. PubMed ID: 25670202 [TBL] [Abstract][Full Text] [Related]
7. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway. Salah Z; Itzhaki E; Aqeilan RI Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971 [TBL] [Abstract][Full Text] [Related]
8. BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling. Verma S; Yeddula N; Soda Y; Zhu Q; Pao G; Moresco J; Diedrich JK; Hong A; Plouffe S; Moroishi T; Guan KL; Verma IM Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7363-7370. PubMed ID: 30918126 [TBL] [Abstract][Full Text] [Related]
9. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Mo JS; Meng Z; Kim YC; Park HW; Hansen CG; Kim S; Lim DS; Guan KL Nat Cell Biol; 2015 Apr; 17(4):500-10. PubMed ID: 25751140 [TBL] [Abstract][Full Text] [Related]
10. TGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation. Pefani DE; Pankova D; Abraham AG; Grawenda AM; Vlahov N; Scrace S; O' Neill E Mol Cell; 2016 Jul; 63(1):156-66. PubMed ID: 27292796 [TBL] [Abstract][Full Text] [Related]
11. LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis. Guo C; Wang X; Liang L Int J Clin Exp Pathol; 2015; 8(2):1690-7. PubMed ID: 25973055 [TBL] [Abstract][Full Text] [Related]
12. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner. Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386 [TBL] [Abstract][Full Text] [Related]
13. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1. Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671 [TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. Hao Y; Chun A; Cheung K; Rashidi B; Yang X J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288 [TBL] [Abstract][Full Text] [Related]
15. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis. Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750 [TBL] [Abstract][Full Text] [Related]
16. Seven in absentia homolog 2 (Siah2) protein is a regulator of NF-E2-related factor 2 (Nrf2). Baba K; Morimoto H; Imaoka S J Biol Chem; 2013 Jun; 288(25):18393-405. PubMed ID: 23645672 [TBL] [Abstract][Full Text] [Related]
18. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor. Zhi X; Zhao D; Zhou Z; Liu R; Chen C Am J Pathol; 2012 Jun; 180(6):2452-61. PubMed ID: 22632819 [TBL] [Abstract][Full Text] [Related]
19. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases. Adler JJ; Johnson DE; Heller BL; Bringman LR; Ranahan WP; Conwell MD; Sun Y; Hudmon A; Wells CD Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17368-73. PubMed ID: 24101513 [TBL] [Abstract][Full Text] [Related]
20. Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility. Wang Z; Wu Y; Wang H; Zhang Y; Mei L; Fang X; Zhang X; Zhang F; Chen H; Liu Y; Jiang Y; Sun S; Zheng Y; Li N; Huang L Proc Natl Acad Sci U S A; 2014 Jan; 111(1):E89-98. PubMed ID: 24367099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]